Fiscal Period | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|
Period End Date | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
Net Income/ Starting Line | 2,023.13 | 1,304.77 | 1,844.28 | 1,842.10 |
Depreciation/ Depletion | 299.30 | 310.42 | 303.96 | 274.58 |
Non- Cash Items | 84.27 | 13.93 | -95.36 | -109.94 |
Changesin Working Capital | -458.63 | 53.38 | -941.86 | -741.84 |
Cashfrom Operating Activities | 1,948.07 | 1,682.50 | 1,111.02 | 1,264.90 |
Capital Expenditures | -259.29 | -232.91 | -338.88 | -194.91 |
Other Investing Cash Flow Items Total | -749.21 | 345.75 | -1,096.25 | -803.63 |
Cashfrom Investing Activities | -1,008.50 | 112.84 | -1,435.13 | -998.54 |
Financing Cash Flow Items | -91.31 | -90.46 | -40.13 | -53.62 |
Total Cash Dividends Paid | -540.49 | -529.52 | -421.91 | -334.78 |
Issuance( Retirement)of Debt Net | -513.21 | -1,302.32 | 841.61 | 116.65 |
Cashfrom Financing Activities | -1,145.01 | -1,760.82 | 379.57 | -271.75 |
Foreign Exchange Effects | -2.05 | 7.10 | 2.50 | 3.67 |
Net Changein Cash | -207.49 | 41.62 | 57.96 | -1.72 |
Cash Interest Paid | 91.31 | 90.46 | 40.13 | 53.62 |
Cash Taxes Paid | 406.94 | 273.39 | 396.90 | 400.68 |
Issuance( Retirement)of Stock Net | - | 161.48 | - | - |
Alkem Laboratories Dividend Alkem Laboratories Bonus Alkem Laboratories News Alkem Laboratories AGM Alkem Laboratories Rights Alkem Laboratories Splits Alkem Laboratories Board Meetings Alkem Laboratories Key Metrics Alkem Laboratories Shareholdings Alkem Laboratories Profit Loss Alkem Laboratories Balance Sheet Alkem Laboratories Q1 Results Alkem Laboratories Q2 Results Alkem Laboratories Q3 Results Alkem Laboratories Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks